Skip to content
Trial Eligibility
Menu

Genomic Predictors of Recurrent Pregnancy Loss

NCT05444283

This study is recruiting at 9 US sites in 8 states, according to its ClinicalTrials.gov record last updated .

Summary

The overall goals of this proposal are to determine the genetic architecture of recurrent pregnancy loss (RPL) and to discover genomic predictors of RPL.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Recurrent Pregnancy Loss

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 50 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Yale University
Last updated on ClinicalTrials.gov
May 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • University of Colorado · Aurora, CO

Connecticut · 1

  • Yale University · New Haven, CT

Illinois · 1

  • Northwestern University · Chicago, IL

Maryland · 1

  • Johns Hopkins University · Baltimore, MD

Michigan · 1

  • Wayne State University · Detroit, MI

New York · 1

  • Columbia University · New York, NY

Pennsylvania · 1

  • Pennsylvania State University · Hershey, PA

Texas · 2

  • University of Texas at Austin · Austin, TX
  • University of Texas at San Antonio · San Antonio, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.